Edwards Lifesciences Corp Company Profile (NYSE:EW)

About Edwards Lifesciences Corp (NYSE:EW)

Edwards Lifesciences Corp logoEdwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:EW
  • CUSIP: 28176E10
  • Web: www.edwards.com
  • Market Cap: $23.95 billion
  • Outstanding Shares: 209,802,000
Average Prices:
  • 50 Day Moving Avg: $104.97
  • 200 Day Moving Avg: $95.34
  • 52 Week Range: $81.12 - $121.75
  • Trailing P/E Ratio: 37.96
  • Foreward P/E Ratio: 28.61
  • P/E Growth: 2.12
Sales & Book Value:
  • Annual Revenue: $3.15 billion
  • Price / Sales: 7.60
  • Book Value: $13.04 per share
  • Price / Book: 8.76
  • EBIDTA: $1.01 billion
  • Net Margins: 19.22%
  • Return on Equity: 25.00%
  • Return on Assets: 15.04%
  • Debt-to-Equity Ratio: 0.31%
  • Current Ratio: 4.21%
  • Quick Ratio: 3.46%
  • Average Volume: 1.84 million shs.
  • Beta: 0.53
  • Short Ratio: 0.73

Frequently Asked Questions for Edwards Lifesciences Corp (NYSE:EW)

What is Edwards Lifesciences Corp's stock symbol?

Edwards Lifesciences Corp trades on the New York Stock Exchange (NYSE) under the ticker symbol "EW."

When did Edwards Lifesciences Corp's stock split? How did Edwards Lifesciences Corp's stock split work?

Shares of Edwards Lifesciences Corp split before market open on Monday, December 14th 2015. The 2-1 split was announced on Thursday, November 19th 2015. The newly created shares were payable to shareholders after the market closes on Friday, December 11th 2015. An investor that had 100 shares of Edwards Lifesciences Corp stock prior to the split would have 200 shares after the split.

How were Edwards Lifesciences Corp's earnings last quarter?

Edwards Lifesciences Corp (NYSE:EW) announced its quarterly earnings results on Tuesday, April, 25th. The company reported $0.94 EPS for the quarter, beating analysts' consensus estimates of $0.82 by $0.12. The firm earned $883.50 million during the quarter, compared to the consensus estimate of $776.51 million. Edwards Lifesciences Corp had a return on equity of 25.00% and a net margin of 19.22%. The business's revenue for the quarter was up 26.7% compared to the same quarter last year. During the same period last year, the firm earned $0.71 EPS. View Edwards Lifesciences Corp's Earnings History.

What guidance has Edwards Lifesciences Corp issued on next quarter's earnings?

Edwards Lifesciences Corp updated its FY17 earnings guidance on Tuesday, April, 25th. The company provided earnings per share (EPS) guidance of $3.43-3.55 for the period, compared to the Thomson Reuters consensus estimate of $3.41. The company issued revenue guidance of $3.2-3.4 billion, compared to the consensus revenue estimate of $3.26 billion.Edwards Lifesciences Corp also updated its Q2 guidance to $0.82-0.92 EPS.

Where is Edwards Lifesciences Corp's stock going? Where will Edwards Lifesciences Corp's stock price be in 2017?

23 brokers have issued 12-month price objectives for Edwards Lifesciences Corp's stock. Their predictions range from $94.00 to $140.00. On average, they expect Edwards Lifesciences Corp's share price to reach $119.19 in the next twelve months. View Analyst Ratings for Edwards Lifesciences Corp.

What are analysts saying about Edwards Lifesciences Corp stock?

Here are some recent quotes from research analysts about Edwards Lifesciences Corp stock:

  • 1. According to Zacks Investment Research, "Edwards Lifesciences exited the first quarter of 2017 on a solid note, with both earnings and revenues beating the Zacks Consensus Estimate. Strong THVT sales were a major upside for the company. The company also performed well on the gross margin front. This bullish result has been reflected in the company’s share price performance too. Over the last three months, Edwards was trading below the broader Medical instruments industry. However, the stock shot up post the first-quarter earnings release. Management expects to gain space in the potential THV market, based on increasing preference in favor of TAVR as well as compelling clinical evidences. On the flip side, higher operating expenses continue to be a concern. The stock’s valuation also remains stretched on huge investments in the launch and promotion of products. Stiff competition, currency fluctuation and reimbursement issues are other challenges for the company." (5/22/2017)
  • 2. Cowen and Company analysts commented, "After hosting meetings with management last week, attending ACC, and reviewing early 1Q'17 MedMine hospital purchasing data, we remain bullish on Edwards' long term growth prospects. We are optimistic that additional layers of growth will be provided by low risk, asymptomatic and moderate AS indications along with EW's mitral and tricuspid platforms. Reiterate Outperform." (3/28/2017)
  • 3. Evercore ISI analysts commented, "With lowered investor expectations, we believe EW shares are poised for a 'catch-up' trade and offers asymmetric risk-reward at current levels. As a result, we are upgrading shares to a Buy, and raising our PT to $110, which offers ~15% upside from current levels." (3/27/2017)
  • 4. Leerink Swann analysts commented, "We derive a $12 price target for EARS using a DCF analysis with a 13% discount rate and a 2% terminal growth rate. Our valuation assumes a 60% probability of approval for AM-101 and a 25% probability of success for AM-111. Upside to our valuation could come from both: (1) off-label use of ’101 in tinnitus of etiologies beyond otitis media and acute acoustic trauma, and (2) the ability of EARS to commercialize AM-111 in the US." (8/19/2016)
  • 5. Canaccord Genuity analysts commented, "We expect current momentum in the US TAVI market to accelerate behind today’s announced S3 IR approval. The FDA announced approval of an expanded indication for EW’s Sapien 3 and Sapien XT valves for the treatment of intermediate risk patients (i.e. STS score 3-10), with S3 and XT representing the first valves approved in the US for use in IR patients." (8/18/2016)

Who are some of Edwards Lifesciences Corp's key competitors?

Who owns Edwards Lifesciences Corp stock?

Edwards Lifesciences Corp's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.63%), BlackRock Inc. (6.63%), State Street Corp (4.48%), Wellington Management Group LLP (3.04%), Alliancebernstein L.P. (3.01%) and Ameriprise Financial Inc. (2.72%). Company insiders that own Edwards Lifesciences Corp stock include Barbara J Mcneil, Bernard J Zovighian, Catherine M Szyman, Donald E Bobo Jr, Donald E Bobo, Jr, Dylan Sidoo, Huimin Wang, John T Cardis, Kieran Gallahue, Larry L Wood, Michael A Mussallem, Nick Demare, Patrick B Verguet, Robert WA Sellers, Schack Wesley W Von, Steven R Loranger and West Petroleum Corp East. View Institutional Ownership Trends for Edwards Lifesciences Corp.

Who sold Edwards Lifesciences Corp stock? Who is selling Edwards Lifesciences Corp stock?

Edwards Lifesciences Corp's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Janus Capital Management LLC, Columbus Circle Investors, Pioneer Investment Management Inc., Marshall Wace LLP, William Blair Investment Management LLC, Point72 Asset Management L.P. and Montag & Caldwell LLC. Company insiders that have sold Edwards Lifesciences Corp stock in the last year include Bernard J Zovighian, Donald E Bobo Jr, Donald E Bobo, Jr, Huimin Wang, John T Cardis, Larry L Wood, Michael A Mussallem, Patrick B Verguet, Robert WA Sellers and Schack Wesley W Von. View Insider Buying and Selling for Edwards Lifesciences Corp.

Who bought Edwards Lifesciences Corp stock? Who is buying Edwards Lifesciences Corp stock?

Edwards Lifesciences Corp's stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Alliancebernstein L.P., MARSHALL WACE ASIA Ltd, Marshall Wace North America L.P., Wedgewood Partners Inc., Ameriprise Financial Inc., Artisan Partners Limited Partnership and Vanguard Group Inc.. Company insiders that have bought Edwards Lifesciences Corp stock in the last two years include Catherine M Szyman, Dylan Sidoo, Kieran Gallahue, Nick Demare, Steven R Loranger and West Petroleum Corp East. View Insider Buying and Selling for Edwards Lifesciences Corp.

How do I buy Edwards Lifesciences Corp stock?

Shares of Edwards Lifesciences Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Edwards Lifesciences Corp stock cost?

One share of Edwards Lifesciences Corp stock can currently be purchased for approximately $114.17.

Analyst Ratings

Consensus Ratings for Edwards Lifesciences Corp (NYSE:EW) (?)
Ratings Breakdown: 1 Sell Rating, 5 Hold Ratings, 16 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.74)
Consensus Price Target: $119.19 (4.40% upside)

Analysts' Ratings History for Edwards Lifesciences Corp (NYSE:EW)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/16/2017Goldman Sachs Group IncInitiated CoverageConviction-Buy$138.00LowView Rating Details
4/26/2017Jefferies Group LLCReiterated RatingBuyLowView Rating Details
4/26/2017Royal Bank of CanadaBoost Price TargetOutperform -> Outperform$116.00 -> $120.00HighView Rating Details
4/26/2017Stifel NicolausBoost Price TargetBuy -> Buy$114.00 -> $118.00HighView Rating Details
3/28/2017Cowen and CompanyReiterated RatingOutperform$120.00MediumView Rating Details
3/27/2017Evercore ISIUpgradeIn-Line -> Outperform$98.50 -> $110.00LowView Rating Details
3/20/2017Northland SecuritiesSet Price TargetBuy$105.00LowView Rating Details
2/8/2017Credit Suisse Group AGSet Price TargetBuy$120.00N/AView Rating Details
2/5/2017Deutsche Bank AGReiterated RatingHold$100.00N/AView Rating Details
2/2/2017Canaccord GenuitySet Price TargetBuy$140.00N/AView Rating Details
2/2/2017Leerink SwannDowngradeOutperform -> Market PerformN/AView Rating Details
2/2/2017BTIG ResearchDowngradeBuy -> NeutralN/AView Rating Details
1/3/2017GuggenheimUpgradeNeutral -> Buy$120.00N/AView Rating Details
12/10/2016JMP SecuritiesReiterated RatingEqual Weight$130.00N/AView Rating Details
12/10/2016Barclays PLCReiterated RatingEqual Weight$100.00N/AView Rating Details
12/1/2016JPMorgan Chase & Co.Set Price TargetBuy$120.00N/AView Rating Details
9/11/2016Wells Fargo & CoReiterated RatingBuyN/AView Rating Details
8/19/2016Morgan StanleyReiterated RatingBuy$140.00N/AView Rating Details
7/27/2016Citigroup IncBoost Price TargetSell$86.00 -> $94.00N/AView Rating Details
7/27/2016BMO Capital MarketsReiterated RatingBuy$120.00N/AView Rating Details
7/27/2016Bank of America CorpUpgradeNeutral -> Buy$130.00N/AView Rating Details
6/21/2016William BlairReiterated RatingOutperformN/AView Rating Details
6/21/2016Piper Jaffray CompaniesReiterated RatingOverweight$123.00N/AView Rating Details
3/17/2016NomuraInitiated CoverageBuy$101.00N/AView Rating Details
3/8/2016SunTrust Banks, Inc.Reiterated RatingBuyN/AView Rating Details
1/4/2016Sterne Agee CRTBoost Price TargetBuy$90.00 -> $92.00N/AView Rating Details
(Data available from 5/25/2015 forward)


Earnings History for Edwards Lifesciences Corp (NYSE:EW)
Earnings by Quarter for Edwards Lifesciences Corp (NYSE:EW)
Earnings History by Quarter for Edwards Lifesciences Corp (NYSE:EW)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2017Q1 2017$0.82$0.94$776.51 million$883.50 millionViewN/AView Earnings Details
2/1/2017Q416$0.72$0.75$760.85 million$767.70 millionViewN/AView Earnings Details
10/25/2016Q316$0.68$0.68$749.14 million$739.40 millionViewN/AView Earnings Details
7/26/2016Q216$0.70$0.76$724.26 million$759.30 millionViewN/AView Earnings Details
4/26/2016Q116$0.66$0.71$664.53 million$697.30 millionViewN/AView Earnings Details
2/2/2016Q415$0.62$0.63$647.44 million$671.10 millionViewN/AView Earnings Details
10/26/2015Q315$0.98$1.07$598.29 million$615.00 millionViewN/AView Earnings Details
7/28/2015Q215$1.05$1.13$604.97 million$616.80 millionViewN/AView Earnings Details
4/23/2015Q115$1.04$1.12$585.16 million$590.30 millionViewN/AView Earnings Details
2/3/2015Q414$0.95$1.06$610.50 million$618.00 millionViewListenView Earnings Details
10/23/2014Q314$0.72$0.80$546.10 million$607.40 millionViewListenView Earnings Details
7/29/2014Q214$0.77$0.88$545.10 million$547.00 millionViewListenView Earnings Details
4/24/2014Q114$0.69$0.76$523.10 million$522.40 millionViewListenView Earnings Details
2/3/2014Q413$0.82$0.91$533.82 million$536.00 millionViewN/AView Earnings Details
10/28/2013Q313$0.66$0.68$490.96 million$496.00 millionViewN/AView Earnings Details
7/25/2013Q2 2013$0.76$0.82$514.59 million$517.20 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.76$0.72$518.69 million$496.70 millionViewN/AView Earnings Details
2/4/2013Q4 2012$0.77$0.77$499.46 million$510.50 millionViewN/AView Earnings Details
10/19/2012$0.56$0.58ViewN/AView Earnings Details
7/24/2012$0.66$0.67ViewN/AView Earnings Details
2/2/2012$0.59$0.62ViewN/AView Earnings Details
10/19/2011$0.39$0.38ViewN/AView Earnings Details
7/21/2011$0.50$0.49ViewN/AView Earnings Details
4/20/2011$0.42$0.51ViewN/AView Earnings Details
2/2/2011$0.53$0.55ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Edwards Lifesciences Corp (NYSE:EW)
2017 EPS Consensus Estimate: $3.40
2018 EPS Consensus Estimate: $3.99
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.82$0.85$0.84
Q2 20174$0.87$0.89$0.88
Q3 20174$0.78$0.84$0.81
Q4 20174$0.86$0.89$0.88
Q1 20183$0.95$1.03$0.99
Q2 20183$0.98$1.04$1.01
Q3 20183$0.92$0.98$0.95
Q4 20183$1.01$1.06$1.04
(Data provided by Zacks Investment Research)


Dividend History for Edwards Lifesciences Corp (NYSE:EW)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Edwards Lifesciences Corp (NYSE:EW)
Insider Ownership Percentage: 2.37%
Institutional Ownership Percentage: 83.99%
Insider Trades by Quarter for Edwards Lifesciences Corp (NYSE:EW)
Institutional Ownership by Quarter for Edwards Lifesciences Corp (NYSE:EW)
Insider Trades by Quarter for Edwards Lifesciences Corp (NYSE:EW)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/19/2017Dylan SidooDirectorBuy25,000$0.11$2,750.00
5/19/2017Patrick B. VerguetVPSell22,631$113.16$2,560,923.96View SEC Filing  
5/15/2017Patrick B. VerguetVPSell11,500$111.64$1,283,860.00View SEC Filing  
5/8/2017Donald E. Bobo, Jr.VPSell19,100$110.34$2,107,494.00View SEC Filing  
5/4/2017Donald E. Bobo, Jr.VPSell34,120$109.98$3,752,517.60View SEC Filing  
5/3/2017Michael A. MussallemCEOSell49,100$109.71$5,386,761.00View SEC Filing  
4/28/2017Michael A. MussallemCEOSell49,100$109.78$5,390,198.00View SEC Filing  
4/27/2017Bernard J. ZovighianVPSell18,050$109.21$1,971,240.50View SEC Filing  
4/5/2017Donald E. Bobo, Jr.VPSell13,720$93.58$1,283,917.60View SEC Filing  
3/30/2017Patrick B. VerguetVPSell24,000$93.90$2,253,600.00View SEC Filing  
3/6/2017Donald E. Bobo, Jr.VPSell13,720$90.01$1,234,937.20View SEC Filing  
2/16/2017Michael A. MussallemCEOSell49,100$89.63$4,400,833.00View SEC Filing  
2/3/2017Kieran GallahueDirectorBuy3,000$90.10$270,300.00View SEC Filing  
1/13/2017Michael A. MussallemCEOSell49,100$97.08$4,766,628.00View SEC Filing  
1/12/2017Donald E. Bobo, Jr.VPSell13,720$97.47$1,337,288.40View SEC Filing  
1/12/2017Dylan SidooDirectorBuy30,000$0.13$3,900.00
1/11/2017Dylan SidooDirectorBuy20,000$0.13$2,600.00
12/19/2016Michael A. MussallemCEOSell49,100$91.96$4,515,236.00View SEC Filing  
12/5/2016Huimin WangVPSell13,650$83.53$1,140,184.50View SEC Filing  
12/1/2016Larry L. WoodVPSell13,258$81.85$1,085,167.30View SEC Filing  
11/30/2016Catherine M. SzymanVPBuy12,870$83.43$1,073,744.10View SEC Filing  
11/29/2016Kieran GallahueDirectorBuy3,000$84.63$253,890.00View SEC Filing  
11/22/2016Michael A. MussallemCEOSell49,100$84.67$4,157,297.00View SEC Filing  
11/7/2016Huimin WangVPSell13,650$91.29$1,246,108.50View SEC Filing  
11/2/2016Donald E. Bobo, Jr.VPSell15,000$90.13$1,351,950.00View SEC Filing  
11/1/2016Larry L. WoodVPSell13,257$93.27$1,236,480.39View SEC Filing  
10/27/2016Michael A. MussallemCEOSell49,100$92.77$4,555,007.00View SEC Filing  
10/5/2016Huimin WangVPSell13,650$120.04$1,638,546.00View SEC Filing  
10/3/2016Larry L. WoodVPSell13,257$119.27$1,581,162.39View SEC Filing  
9/6/2016Huimin WangVPSell13,650$115.72$1,579,578.00View SEC Filing  
9/2/2016Donald E. Bobo, Jr.VPSell18,000$115.78$2,084,040.00View SEC Filing  
8/26/2016Patrick B. VerguetVPSell5,000$114.88$574,400.00View SEC Filing  
8/24/2016Patrick B. VerguetVPSell5,000$116.81$584,050.00View SEC Filing  
8/23/2016Patrick B. VerguetVPSell10,092$117.53$1,186,112.76View SEC Filing  
8/11/2016Michael A. MussallemCEOSell49,100$114.01$5,597,891.00View SEC Filing  
8/10/2016John T. CardisDirectorSell5,000$113.21$566,050.00View SEC Filing  
8/9/2016Patrick B. VerguetVPSell10,000$113.48$1,134,800.00View SEC Filing  
8/5/2016Huimin WangVPSell13,650$113.03$1,542,859.50View SEC Filing  
8/1/2016Larry L. WoodVPSell13,257$114.24$1,514,479.68View SEC Filing  
8/1/2016Schack Wesley W. VonDirectorSell6,000$113.98$683,880.00View SEC Filing  
7/29/2016Robert W.A. SellersVPSell10,000$114.33$1,143,300.00View SEC Filing  
7/28/2016Michael A. MussallemCEOSell49,100$113.31$5,563,521.00View SEC Filing  
7/5/2016Huimin WangVPSell13,650$98.44$1,343,706.00View SEC Filing  
7/1/2016Larry L. WoodVPSell13,257$98.79$1,309,659.03View SEC Filing  
6/8/2016Michael A MussallemCEOSell49,100$102.75$5,045,025.00View SEC Filing  
6/6/2016Huimin WangVPSell13,650$101.34$1,383,291.00View SEC Filing  
6/3/2016Larry L WoodVPSell13,257$101.38$1,343,994.66View SEC Filing  
5/31/2016Donald E Bobo JrVPSell18,000$99.04$1,782,720.00View SEC Filing  
5/24/2016Steven R LorangerDirectorBuy5,000$101.07$505,350.00View SEC Filing  
5/18/2016Patrick B VerguetVPSell13,000$102.75$1,335,750.00View SEC Filing  
5/17/2016Patrick B VerguetVPSell5,000$105.00$525,000.00View SEC Filing  
5/16/2016Patrick B VerguetVPSell3,000$104.62$313,860.00View SEC Filing  
5/5/2016Huimin WangVPSell13,650$103.36$1,410,864.00View SEC Filing  
5/5/2016Michael A MussallemCEOSell59,000$104.12$6,143,080.00View SEC Filing  
5/2/2016Patrick B VerguetVPSell7,000$106.86$748,020.00View SEC Filing  
4/29/2016Michael A MussallemCEOSell59,000$106.13$6,261,670.00View SEC Filing  
4/5/2016Huimin WangVPSell13,650$103.97$1,419,190.50View SEC Filing  
3/17/2016Michael A MussallemCEOSell59,000$84.39$4,979,010.00View SEC Filing  
3/7/2016Huimin WangVPSell13,650$87.17$1,189,870.50View SEC Filing  
2/18/2016Michael A. MussallemCEOSell59,000$86.94$5,129,460.00View SEC Filing  
2/18/2016Patrick B. VerguetVPSell5,000$87.00$435,000.00View SEC Filing  
2/16/2016Patrick B. VerguetVPSell8,000$81.58$652,640.00View SEC Filing  
2/5/2016Huimin WangVPSell13,650$83.46$1,139,229.00View SEC Filing  
2/4/2016Barbara J. McneilDirectorSell4,000$83.29$333,160.00View SEC Filing  
1/21/2016Patrick B. VerguetVPSell8,000$77.00$616,000.00View SEC Filing  
1/6/2016Nick DemareDirectorBuy15,000$0.08$1,200.00
1/5/2016Huimin WangVPSell13,650$78.50$1,071,525.00View SEC Filing  
1/5/2016Michael A. MussallemCEOSell59,000$79.82$4,709,380.00View SEC Filing  
12/17/2015Michael A. MussallemCEOSell59,000$81.85$4,829,150.00View SEC Filing  
12/15/2015Patrick B. VerguetVPSell8,000$80.87$646,960.00View SEC Filing  
12/4/2015Huimin WangVPSell6,880$157.96$1,086,764.80View SEC Filing  
11/27/2015Patrick B. VerguetVPSell7,500$164.50$1,233,750.00View SEC Filing  
11/23/2015Robert W.A. SellersVPSell19,200$157.13$3,016,896.00View SEC Filing  
11/17/2015Patrick B. VerguetVPSell4,000$154.50$618,000.00View SEC Filing  
11/5/2015Huimin WangVPSell6,920$156.01$1,079,589.20View SEC Filing  
11/3/2015Patrick B. VerguetVPSell4,338$158.48$687,486.24View SEC Filing  
10/30/2015Patrick B. VerguetVPSell22,000$155.09$3,411,980.00View SEC Filing  
10/29/2015Michael A MussallemCEOSell29,500$154.59$4,560,405.00View SEC Filing  
10/5/2015Huimin WangVPSell6,920$154.30$1,067,756.00View SEC Filing  
10/2/2015Patrick B. VerguetVPSell4,000$154.00$616,000.00View SEC Filing  
10/1/2015Larry L. WoodVPSell7,680$141.52$1,086,873.60View SEC Filing  
9/21/2015Michael A. MussallemCEOSell29,500$142.49$4,203,455.00View SEC Filing  
9/4/2015Huimin WangVPSell6,920$135.19$935,514.80View SEC Filing  
9/1/2015Larry L. WoodVPSell7,680$137.50$1,056,000.00View SEC Filing  
8/24/2015Michael A. MussallemCEOSell29,500$135.25$3,989,875.00View SEC Filing  
8/13/2015West Petroleum Corp. EastInsiderBuy25,000$0.12$2,875.00
7/6/2015Huimin WangVPSell6,920$143.95$996,134.00View SEC Filing  
7/1/2015Larry L WoodVPSell7,680$143.51$1,102,156.80View SEC Filing  
6/24/2015Michael A MussallemCEOSell29,500$143.71$4,239,445.00View SEC Filing  
6/5/2015Huimin WangVPSell6,920$131.39$909,218.80View SEC Filing  
6/1/2015Larry L WoodVPSell7,680$130.47$1,002,009.60View SEC Filing  
5/29/2015Patrick B VerguetVPSell9,662$131.18$1,267,461.16View SEC Filing  
5/21/2015Barbara J McneilDirectorSell2,000$132.59$265,180.00View SEC Filing  
5/19/2015Robert Marc BustinDirectorSell10,000$0.18$1,750.00
5/1/2015Larry L WoodVPSell7,680$127.12$976,281.60View SEC Filing  
4/30/2015Michael A MussallemCEOSell29,500$128.99$3,805,205.00View SEC Filing  
4/6/2015Huimin WangVPSell6,920$140.24$970,460.80View SEC Filing  
4/1/2015Larry L WoodVPSell7,680$142.06$1,091,020.80View SEC Filing  
3/31/2015Robert Marc BustinDirectorBuy15,000$0.15$2,250.00
3/26/2015Michael A MussallemCEOSell29,500$140.10$4,132,950.00View SEC Filing  
3/2/2015Larry L WoodVPSell7,680$132.62$1,018,521.60View SEC Filing  
2/6/2015Huimin WangVPSell6,920$134.79$932,746.80View SEC Filing  
1/5/2015Huimin WangVPSell6,920$126.60$876,072.00View SEC Filing  
1/5/2015Michael A MussallemCEOSell29,500$128.20$3,781,900.00View SEC Filing  
12/22/2014Michael A MussallemCEOSell29,500$133.01$3,923,795.00View SEC Filing  
11/24/2014Michael A MussallemCEOSell29,500$124.25$3,665,375.00View SEC Filing  
11/13/2014Robert W.A. SellersVPSell3,400$124.27$422,518.00View SEC Filing  
11/10/2014Patrick B VerguetVPSell5,000$123.70$618,500.00View SEC Filing  
11/7/2014Schack Wesley W VonDirectorSell3,655$123.00$449,565.00View SEC Filing  
11/5/2014Huimin WangVPSell5,600$120.26$673,456.00View SEC Filing  
10/28/2014Barbara J McneilDirectorSell1,000$117.94$117,940.00View SEC Filing  
10/28/2014Michael A MussallemCEOSell29,500$117.06$3,453,270.00View SEC Filing  
10/28/2014Patrick B VerguetVPSell15,000$117.33$1,759,950.00View SEC Filing  
10/28/2014West Petroleum Corp. EastInsiderBuy15,000$0.12$1,800.00
10/27/2014Patrick B VerguetVPSell10,000$117.00$1,170,000.00View SEC Filing  
10/27/2014West Petroleum Corp. EastInsiderBuy20,000$0.13$2,600.00
10/24/2014Donald E Bobo JrVPSell30,000$114.25$3,427,500.00View SEC Filing  
10/24/2014West Petroleum Corp. EastInsiderBuy35,000$0.14$4,725.00
10/23/2014West Petroleum Corp. EastInsiderBuy40,000$0.15$5,800.00
10/6/2014Huimin WangVPSell5,600$107.00$599,200.00View SEC Filing  
10/3/2014Donald E Bobo JrVPSell25,000$105.00$2,625,000.00View SEC Filing  
9/29/2014Michael A MussallemCEOSell29,500$102.71$3,029,945.00View SEC Filing  
9/10/2014Donald E Bobo JrVPSell25,000$100.00$2,500,000.00View SEC Filing  
9/5/2014Huimin WangVPSell5,600$98.29$550,424.00View SEC Filing  
8/27/2014Carlyn D SolomonVPSell85,200$97.85$8,336,820.00View SEC Filing  
8/27/2014Michael A MussallemCEOSell29,500$98.14$2,895,130.00View SEC Filing  
8/18/2014John T CardisDirectorSell6,000$97.92$587,520.00View SEC Filing  
8/18/2014Larry L WoodVPSell63,752$97.85$6,238,133.20View SEC Filing  
8/13/2014Patrick B VerguetVPSell7,800$95.50$744,900.00View SEC Filing  
8/5/2014Patrick B VerguetVPSell15,000$94.05$1,410,750.00View SEC Filing  
8/4/2014Patrick B VerguetVPSell5,000$93.00$465,000.00View SEC Filing  
8/1/2014Patrick B VerguetVPSell5,000$92.00$460,000.00View SEC Filing  
7/31/2014Michael A MussallemCEOSell29,500$91.98$2,713,410.00View SEC Filing  
7/31/2014Robert Alexander IngramDirectorSell12,500$90.26$1,128,250.00View SEC Filing  
7/31/2014Robert W.A. SellersVPSell8,850$91.47$809,509.50View SEC Filing  
7/30/2014Donald E Bobo JrVPSell23,270$92.00$2,140,840.00View SEC Filing  
7/7/2014Huimin WangVPSell5,600$87.79$491,624.00View SEC Filing  
6/27/2014Donald E Bobo JrVPSell25,000$87.00$2,175,000.00View SEC Filing  
6/24/2014Michael A MussallemCEOSell29,500$85.38$2,518,710.00View SEC Filing  
6/5/2014Huimin WangVPSell5,600$80.73$452,088.00View SEC Filing  
5/30/2014Barbara J McneilDirectorSell1,200$81.20$97,440.00View SEC Filing  
5/28/2014Michael A MussallemCEOSell29,500$79.33$2,340,235.00View SEC Filing  
4/14/2014Donald Bobo, Jr.VPSell25,000$82.00$2,050,000.00View SEC Filing  
4/10/2014Michael MussallemCEOSell29,500$74.71$2,203,945.00View SEC Filing  
4/7/2014Huimin WangVPSell5,600$74.03$414,568.00View SEC Filing  
3/24/2014Michael BowlinDirectorSell1,093$72.33$79,056.69View SEC Filing  
3/6/2014Robert W.A. SellersVPSell1,650$72.88$120,252.00View SEC Filing  
2/6/2014Michael MussallemCEOSell29,500$66.92$1,974,140.00View SEC Filing  
1/27/2014Michael BowlinDirectorSell1,092$68.65$74,965.80View SEC Filing  
1/9/2014Michael MussallemCEOSell29,500$67.04$1,977,680.00View SEC Filing  
1/6/2014Huimin WangVPSell5,600$67.14$375,984.00View SEC Filing  
12/11/2013Patrick VerguetVPSell10,000$62.34$623,400.00View SEC Filing  
12/5/2013Huimin WangVPSell4,650$64.65$300,622.50View SEC Filing  
12/4/2013Michael MussallemCEOSell29,500$64.90$1,914,550.00View SEC Filing  
10/9/2013Michael MussallemCEOSell29,500$72.63$2,142,585.00View SEC Filing  
10/4/2013Huimin WangVPSell4,850$72.19$350,121.50View SEC Filing  
9/12/2013Michael MussallemCEOSell29,500$71.82$2,118,690.00View SEC Filing  
9/5/2013Huimin WangVPSell4,850$71.24$345,514.00View SEC Filing  
8/8/2013Michael MussallemCEOSell29,500$72.28$2,132,260.00View SEC Filing  
8/5/2013Huimin WangVPSell4,850$72.30$350,655.00View SEC Filing  
8/1/2013Patrick VerguetVPSell20,000$73.15$1,463,000.00View SEC Filing  
7/10/2013Michael A MussallemCEOSell29,500$65.60$1,935,200.00View SEC Filing  
7/5/2013Huimin WangVPSell4,850$65.69$318,596.50View SEC Filing  
6/6/2013Michael A MussallemCEOSell29,500$66.25$1,954,375.00View SEC Filing  
6/5/2013Huimin WangVPSell4,850$65.11$315,783.50View SEC Filing  
5/13/2013Paul C RedmondVPSell5,000$67.35$336,750.00View SEC Filing  
5/8/2013Michael A MussallemCEOSell29,200$64.24$1,875,808.00View SEC Filing  
5/7/2013Thomas M AbateCFOSell15,000$63.75$956,250.00View SEC Filing  
5/3/2013Schack Wesley W VonDirectorBuy1,000$64.00$64,000.00View SEC Filing  
5/1/2013David E I PyottDirectorBuy3,000$62.95$188,850.00View SEC Filing  
5/1/2013John H Kehl JrVPSell12,500$62.72$784,000.00View SEC Filing  
4/26/2013Schack Wesley W VonDirectorBuy2,000$64.95$129,900.00View SEC Filing  
4/10/2013Michael A MussallemCEOSell35,000$83.37$2,917,950.00View SEC Filing  
3/13/2013John H Kehl JrVPSell12,500$87.75$1,096,875.00View SEC Filing  
10/5/2012Huimin WangVPSell6,250$109.88$686,750.00View SEC Filing  
10/4/2012Donald E Bobo JrVPSell11,530$110.14$1,269,914.20View SEC Filing  
8/9/2012Michael A MussallemCEOSell35,000$98.69$3,454,150.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Edwards Lifesciences Corp (NYSE:EW)
Latest Headlines for Edwards Lifesciences Corp (NYSE:EW)
nasdaq.com logoAlign Technology Rises with Invisalign, SmartTrack Patents - Nasdaq
www.nasdaq.com - May 25 at 7:10 PM
americanbankingnews.com logoEdwards Lifesciences Corp (EW) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - May 23 at 8:22 PM
finance.yahoo.com logoIntegra Lifesciences Hits 52-Week High on Product Launches
finance.yahoo.com - May 22 at 4:45 PM
americanbankingnews.com logoEdwards Lifesciences Corp (EW) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - May 22 at 3:50 PM
americanbankingnews.com logoInsider Selling: Edwards Lifesciences Corp (EW) VP Sells 22,631 Shares of Stock
www.americanbankingnews.com - May 19 at 7:40 PM
finance.yahoo.com logoEdwards Lifesciences' Every Heartbeat Matters Initiative On Track To Impact 1 Million Underserved People By 2020
finance.yahoo.com - May 19 at 5:39 AM
americanbankingnews.com logoSunTrust Banks Analysts Lift Earnings Estimates for Edwards Lifesciences Corp (EW)
www.americanbankingnews.com - May 18 at 3:32 PM
americanbankingnews.com logoEdwards Lifesciences Corp (EW) Downgraded by Zacks Investment Research
www.americanbankingnews.com - May 18 at 1:33 PM
finance.yahoo.com logoMedtronic's MyCareLink Data on Older Patients Found Positive
finance.yahoo.com - May 18 at 10:18 AM
finance.yahoo.com logoBoston Scientific's Symetis Buyout Boosts Structural Heart
finance.yahoo.com - May 18 at 10:18 AM
americanbankingnews.com logoEdwards Lifesciences Corp (EW) to Post FY2020 Earnings of $5.19 Per Share, SunTrust Banks Forecasts
www.americanbankingnews.com - May 17 at 2:52 PM
nasdaq.com logoWhy Edwards Lifesciences (EW) Isn't Done Growing Earnings Yet
www.nasdaq.com - May 17 at 10:50 AM
finance.yahoo.com logoEdwards' Novel Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes
finance.yahoo.com - May 17 at 10:50 AM
finance.yahoo.com logoWhy Edwards Lifesciences (EW) Isn't Done Growing Earnings Yet
finance.yahoo.com - May 17 at 10:50 AM
finance.yahoo.com logoHold on Concert's Hair Loss Trials Pushes Shares Down 10%
finance.yahoo.com - May 17 at 10:49 AM
americanbankingnews.com logoEdwards Lifesciences Corp (EW) Now Covered by Analysts at Goldman Sachs Group Inc
www.americanbankingnews.com - May 16 at 8:56 PM
americanbankingnews.com logoZacks Investment Research Upgrades Edwards Lifesciences Corp (EW) to Buy
www.americanbankingnews.com - May 16 at 1:34 PM
finance.yahoo.com logoReal-World Evidence With Edwards SAPIEN 3 Transcatheter Valve Confirms Beneficial Patient Outcomes From Clinical Trials
finance.yahoo.com - May 16 at 11:50 AM
americanbankingnews.com logoEdwards Lifesciences Corp (EW) Stock Rating Lowered by Vetr Inc.
www.americanbankingnews.com - May 16 at 12:34 AM
americanbankingnews.com logoEdwards Lifesciences Corp (EW) VP Sells $1,283,860.00 in Stock
www.americanbankingnews.com - May 15 at 7:10 PM
finance.yahoo.com logoETFs with exposure to Edwards Lifesciences Corp. : May 15, 2017
finance.yahoo.com - May 15 at 4:46 PM
americanbankingnews.com logoDonald E. Bobo, Jr. Sells 19,100 Shares of Edwards Lifesciences Corp (EW) Stock
www.americanbankingnews.com - May 9 at 10:21 PM
finance.yahoo.com logoHuge 1Q Surprises May Send These Stocks Higher
finance.yahoo.com - May 8 at 9:09 AM
americanbankingnews.com logoQ1 2018 EPS Estimates for Edwards Lifesciences Corp Lifted by SunTrust Banks (EW)
www.americanbankingnews.com - May 5 at 5:24 PM
americanbankingnews.com logoInsider Selling: Edwards Lifesciences Corp (EW) VP Sells 34,120 Shares of Stock
www.americanbankingnews.com - May 5 at 8:08 AM
americanbankingnews.com logoInsider Selling: Edwards Lifesciences Corp (EW) CEO Sells 49,100 Shares of Stock
www.americanbankingnews.com - May 5 at 8:08 AM
americanbankingnews.com logoEdwards Lifesciences Corp (EW) Upgraded at Vetr Inc.
www.americanbankingnews.com - May 5 at 12:12 AM
finance.yahoo.com logoEdwards Lifesciences To Webcast Annual Meeting Of Stockholders
finance.yahoo.com - May 4 at 12:29 PM
americanbankingnews.com logoEquities Analysts Set Expectations for Edwards Lifesciences Corp's Q2 2017 Earnings (EW)
www.americanbankingnews.com - May 4 at 8:28 AM
finance.yahoo.com logoETFs with exposure to Edwards Lifesciences Corp. : May 3, 2017
finance.yahoo.com - May 3 at 4:55 PM
bizjournals.com logoResearch Reports Initiation on Medical Equipment Stocks -- Edwards Lifesciences, Hologic, and Stryker
www.bizjournals.com - May 3 at 10:33 AM
americanbankingnews.com logoSomewhat Favorable Press Coverage Likely to Impact Edwards Lifesciences Corp (EW) Stock Price
www.americanbankingnews.com - May 3 at 1:05 AM
finance.yahoo.com logoEdwards Lifesciences Corp. :EW-US: Earnings Analysis: Q1, 2017 By the Numbers : May 2, 2017
finance.yahoo.com - May 2 at 5:54 PM
finance.yahoo.com logoEdwards Lifesciences CEO: Bigger isn't better, we're focu...
finance.yahoo.com - May 2 at 5:54 PM
americanbankingnews.com logoEdwards Lifesciences Corp (EW) CEO Michael A. Mussallem Sells 49,100 Shares
www.americanbankingnews.com - May 1 at 11:28 PM
americanbankingnews.com logoSomewhat Positive News Coverage Likely to Affect Edwards Lifesciences Corp (EW) Stock Price
www.americanbankingnews.com - April 29 at 11:33 PM
americanbankingnews.com logoEdwards Lifesciences Corp (EW) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - April 29 at 1:13 AM
americanbankingnews.com logoInsider Selling: Edwards Lifesciences Corp (EW) VP Sells 18,050 Shares of Stock
www.americanbankingnews.com - April 29 at 12:40 AM
finance.yahoo.com logo[$$] Edward Lifesciences helps healthcare stocks extend run
finance.yahoo.com - April 28 at 6:10 PM
americanbankingnews.com logoEdwards Lifesciences Corp (EW) to Post Q2 2017 Earnings of $0.89 Per Share, Leerink Swann Forecasts
www.americanbankingnews.com - April 28 at 10:12 AM
247wallst.com logoWednesday's Biggest Winners and Losers in the S&P 500 - 24/7 Wall St.
247wallst.com - April 27 at 5:37 PM
nasdaq.com logoEarnings Reaction History: Edwards Lifesciences Corp., 70.0% Follow-Through Indicator, 6.8% Sensitive - Nasdaq
www.nasdaq.com - April 27 at 5:37 PM
fool.com logoHere's What's Pumping Up Shares of Edwards Lifesciences Corp. Today - Motley Fool
www.fool.com - April 27 at 5:37 PM
finance.yahoo.com logoEdwards Lifesciences Is Not Skipping A Beat
finance.yahoo.com - April 27 at 5:37 PM
americanbankingnews.com logoLeerink Swann Brokers Cut Earnings Estimates for Edwards Lifesciences Corp (EW)
www.americanbankingnews.com - April 27 at 11:34 AM
finance.yahoo.com logoEdwards Lifesciences To Present At The Deutsche Bank 42nd Annual Health Care Conference
finance.yahoo.com - April 27 at 11:20 AM
americanbankingnews.com logoJefferies Group Analysts Increase Earnings Estimates for Edwards Lifesciences Corp (EW)
www.americanbankingnews.com - April 27 at 9:16 AM
americanbankingnews.com logoZacks: Brokerages Anticipate Edwards Lifesciences Corp (EW) to Announce $0.87 Earnings Per Share
www.americanbankingnews.com - April 27 at 9:06 AM
americanbankingnews.com logoEdwards Lifesciences Corp (EW) Downgraded by Vetr Inc.
www.americanbankingnews.com - April 27 at 1:05 AM
americanbankingnews.com logoEdwards Lifesciences Corp (EW) Downgraded to "Hold" at Vetr Inc.
www.americanbankingnews.com - April 27 at 1:05 AM



Edwards Lifesciences Corp (EW) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by MarketBeat.com Staff